asset sale
Basilea buys clinical-stage antifungal from Eisai, advances its anti-infective strategy
Anika Sharma
Basilea Pharmaceutica is making a strategic move to bolster its anti-infective pipeline, this time with a $2 million investment in ...
Glenmark sells API business to Nirma for $681M, wipes out debt
Anika Sharma
Glenmark Pharmaceuticals has successfully resolved its long-standing debt issue by divesting 75% of its active pharmaceutical ingredient (API) business. The ...
